University Medical Center Utrecht
Utrecht, Netherlands
NCT Number: NCT04120298
Currently, the effect of exercise on metastatic breast cancer has not been extensively studied, even though the benefits are evident in the curative setting. The investigators designed the EFFECT study to assess the effects of a 9-month structured and individualised exercise intervention in 350 patients with metastatic breast cancer (stage IV) on cancer-related physical fatigue, Health-Related Quality of Life (HRQoL), and other disease and treatment-related side effects at six months (primary endpoint).
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Utrecht, Netherlands
The EFFECT study is a multicentre, randomised controlled trial. The intervention group will participate in a 9-month exercise intervention. The exercise program will start with a 6-month period, where patients participate in a supervised multimodal exercise program twice a week supplemented with unsupervised exercises. The multimodal exercise program comprises aerobic-, resistance- and balance components. After completing the initial six-month period, one supervised session will be replaced by one unsupervised session until month nine.
Unsupervised exercises will be supported by an activity tracker (FitBit) and an exercise App specifically designed for the EFFECT trial. Patients randomized to the control group will also receive an activity tracker (like the intervention group). The investigators will advice control patients to avoid inactivity and be as physically active as current abilities and conditions allow, with the aim to progress towards being physically active for 150min/week in line with the current exercise guidelines.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An individualised exercise programme supervised by a trained instructor
Time frame: 0- 6 months (measured at baseline, 3 and 6 months)
Physical fatigue measured with the EORTC QLQ-FA12
Time frame: 0- 6 months (measured at baseline, 3 and 6 months)
Disease specific HRQoL measured with the EORTC QLQ-C30 Summary Score
Time frame: 0-9 months
EORTC QLQ-C30 function and symptom scores scores
Time frame: 0-9 months
EORTC QLQ-FA12 scores
Time frame: 0-9 months
EORTC QLQ-BR45
Time frame: 0-9 months
PHQ-4
Time frame: 0-9 months
PSQI
Time frame: 0-9 months
BPI
Time frame: 0-9 months
painDETECT
Time frame: 0-9 months
PCS
Time frame: 0-9 months
Common Toxicity Criteria for adverse events (CTCAE)
Time frame: 0-6 months
weight measured in KG
Time frame: 0-6 months
Height measured in meters
Time frame: 0-6 months
waist circumference measured in cm
Time frame: 0-6 months
Bioelectrical impedance analysis (BIA), add-on in some centers (not obligatory): DEXA
Time frame: 0-6-9 months
Questionnaire
Time frame: 0-6-9 months
activity tracker
Time frame: 0-6 months
Resting heart rate
Time frame: 0-6 months
Blood pressure (diastolic and systolic) measured at rest
Time frame: 0-6 months
Short Physical Performance Battery, handgrip- and leg strength test
Time frame: 0-6 months
Steep ramp test and endurance cycle test, add-on (not obligatory): CPET
Time frame: 0-9 months
iPCQ/iMCQ
Time frame: 0-9 months
Cost analyses
Time frame: 0-9 months
EQ-5D-5L
Time frame: 0-9 months
Self-developed questionnaire
Time frame: 0-6 months
Blood samples (plasma, serum, buffy coat and peripheral blood mononuclear cells (PBMC) )
Time frame: 0-9 months
Progress or disease control of the breast cancer will be derived from medical records and/or the cancer registry
Time frame: 0-9 months
The type and duration of cancer treatment during the study will be derived from medical records and/or the cancer registry
Time frame: 0-9 months
QWLQ-CS (add-on in several centers)
Time frame: 0-60 months
Exploratory outcome
Time frame: 0-60 months
Exploratory outcome
Time frame: 0-9 months
(Serious) Adverse events potentially related to the exercise intervention
Time frame: 0-9 months
Exploratory outcome (add on in some centers) - measured with ICIQ-UI
Time frame: 0-9 months
Exploratory outcome (add on in one center) - Isokinetic and isometric legstrength measured with peak torque / Muscle thickness with ultrasound protocol
UMC Utrecht
Other
Effects of Structured and Individualized Exercise in Patients With Metastatic Breast Cancer on Fatigue and Quality of Life
Acronym: EFFECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07693985
Adherence Interventions, Behavior
Valencia, Spain
View Trial DetailsNCT04354233
Behavior, Breast Diseases
Amiens, France
View Trial DetailsNCT07313306
Behavior, Breast Cancer
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06343987
Adiposity, Behavior
Aarhus N, Central Jutland, Denmark
View Trial Details